ClinVar Miner

Submissions for variant NM_015046.7(SETX):c.4020_4022del (p.Lys1341del)

dbSNP: rs769558791
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000992936 SCV001145549 likely benign not provided 2019-01-28 criteria provided, single submitter clinical testing
Invitae RCV001858762 SCV002258270 uncertain significance Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 2023-01-26 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 805415). This variant has not been reported in the literature in individuals affected with SETX-related conditions. This variant is present in population databases (rs769558791, gnomAD 0.06%). This variant, c.4020_4022del, results in the deletion of 1 amino acid(s) of the SETX protein (p.Lys1341del), but otherwise preserves the integrity of the reading frame.
Ambry Genetics RCV002354901 SCV002620850 uncertain significance Inborn genetic diseases 2020-03-11 criteria provided, single submitter clinical testing The c.4020_4022delGAA variant (also known as p.K1341del) is located in coding exon 8 of the SETX gene. This variant results from an in-frame GAA deletion at nucleotide positions 4020 to 4022. This results in the in-frame deletion of a lysine at codon 1341. This amino acid position is highly conserved in available vertebrate species. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant SETX-related juvenile amyotrophic lateral sclerosis 4 (ALS4); however, its contribution to the development of autosomal recessive SETX-related spinocerebellar ataxia with axonal neuropathy 2 (SCAN2) is uncertain.
GeneDx RCV000992936 SCV004170381 uncertain significance not provided 2023-10-19 criteria provided, single submitter clinical testing In-frame deletion of 1 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.